VOYA Investment Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $97.2K | Sell |
|
|||||
|
2024
Q3 | $177K | Sell |
|
|||||
|
2024
Q2 | $90.9K | Buy |
|
|||||
|
2024
Q1 | $142K | Sell |
|
|||||
|
2023
Q4 | $301K | Buy |
|
|||||
|
2023
Q3 | $384K | Buy |
|
|||||
|
2023
Q2 | $838K | Buy |
|
|||||
|
2023
Q1 | $983K | Hold |
|
|||||
|
2022
Q4 | $563K | Buy |
|
|||||
|
2022
Q3 | $749K | Buy |
|
|||||
|
2022
Q2 | $375K | Sell |
|
|||||
|
2022
Q1 | $541K | Hold |
|
|||||
|
2021
Q4 | $453K | Buy |
|
|||||
|
2021
Q3 | $764K | Hold |
|
|||||
|
2021
Q2 | $813K | Sell |
|
|||||
|
2021
Q1 | $774K | Buy |
|
|||||
|
2020
Q4 | $783K | Buy |
|
|||||
|
2020
Q3 | $528K | Buy |
|
|||||
|
2020
Q2 | $490K | Sell |
|
|||||
|
2020
Q1 | $371K | Buy |
|
|||||
|
2019
Q4 | $354K | Buy |
|
|||||
|
2019
Q3 | $215K | Buy |
|
|||||
|
2019
Q2 | $205K | Buy |
|
|||||
|
2019
Q1 | $214K | Hold |
|
|||||
|
2018
Q4 | $274K | Buy |
|
|||||
|
2018
Q3 | $309K | Hold |
|
|||||
|
2018
Q2 | $341K | Buy |
|
|||||
|
2018
Q1 | $320K | Hold |
|
|||||
|
2017
Q4 | $372K | Hold |
|
|||||
|
2017
Q3 | $286K | Hold |
|
|||||
|
2017
Q2 | $274K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $202K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $242K | Buy |
|